KRISHGEN BioSystems Drug discovery > Drug Manufacturing Products & Reviews

The Ustekinumab ELISA kit is intended for the quantitative determination of Ustekinumab in serum, plasma and cell culture samples.

The Adalimumab (Humira) ELISA kit is intended for the quantitative determination of Adalimumab (Humira) in serum, plasma and cell culture samples. CE IVD marked. Calibrated against NIBSC International Standards from WHO (17/236).

The Eculizumab ELISA kit is intended for the quantitative determination of Eculizumab in serum, plasma and cell culture samples.

This Degarelix ELISA kit is intended for the quantitative determination of Degarelix in serum, plasma and cell culture samples.

Immunoassay for quantitative estimation of Teriparatide in human  serum and plasma.

The Tocilizumab ELISA kit is intended for the quantitative determination of Tocilizumab in serum, plasma and cell culture samples.

The Natalizumab ELISA kit is an assay intended for the quantitative determination of Natalizumab in serum, plasma and cell culture samples.

The Vedolizumab ELISA kit is intended for the quantitative determination of Vedolizumab in serum, plasma and cell culture samples.

The Daratumumab (Darzalex) ELISA kit is an assay intended for the quantitative determination of Daratumumab (Darzalex) in serum, plasma and cell culture samples.

The Pembrolizumab ELISA kit is intended for the quantitative determination of Pembrolizumab in serum, plasma and cell culture samples. RUO only.

ELISA for the quantitative determination of Leuprolide / Leuprorelin in serum and plasma.

Immunoassay for quantitative estimation of Glatiramer Acetate in human serum and plasma. Validated for both serum and plasma samples, this Exenatide ELISA gives specific, accurate results with a ready-to-use assay format.

The Rituximab ELISA kit is intended for the quantitative determination of Rituximab in serum, plasma and cell culture samples. Validated against International NIBSC standards by WHO.

Enzyme Immunoassay for the quantitative determination of Dasatinib in serum, plasma and cell culture supernatant.

The Nivolumab ELISA kit is an assay intended for the quantitative determination of Nivolumab in serum, plasma and cell culture samples.

Enzyme Immunoassay for the quantitative determination of Anti-Atezolizumab antibodies in serum and plasma.

The Infliximab ELISA kit is intended for the quantitative determination of Infliximab in serum, plasma and cell culture samples. Validated against NIBSC international standards from WHO.

Enzyme Immunoassay for the quantitative determination of Anti-Natalizumab antibodies in serum and plasma.

Enzyme Immunoassay for the quantitative determination of Sacituzumab Govitecan in human serum and plasma.

Immunoassay for the measurement of Bovine Serum Albumin in cell culture samples.

The Desmpressin ELISA kit is intended for the quantitative determination of Desmopressin in serum and plasma samples.

Enzyme Immunoassay for the quantitative determination of Anti-Adalimumab antibodies in human serum and plasma.